Sign In
Get Clay Free →

Suggestions

    Bme Sandra McPhail

    Director & Global Process Owner at GlaxoSmithKline

    Professional Background

    Bme Sandra McPhail is a seasoned professional in the biomedical engineering and pharmaceutical industries, boasting a comprehensive background that spans various roles at esteemed organizations. Currently, she serves as the Director and Global Process Owner of Periodic Reporting at GlaxoSmithKline Pharma GmbH, where she plays a pivotal role in ensuring that drug safety protocols are meticulously followed and that regulatory requirements are consistently met. This position underscores her expertise in clinical safety and risk management, reflecting years of dedication and commitment to enhancing patient safety through rigorous evaluation practices.

    Prior to her current role, McPhail was instrumental in several key positions at GlaxoSmithKline, exemplifying her versatility and deep understanding of the drug development landscape. She served as Manager of Safety Evaluation and Risk Management, where she led initiatives to assess potential risks associated with pharmaceutical products. Her earlier work as a Principal Clinical Safety Scientist further solidified her expertise in safety evaluation processes, contributing significantly to safeguarding public health.

    Bme’s journey in the safety and pharmaceutical sector began with her contract role as a Drug Safety Scientist at Talecris Biotherapeutics, Inc., where she honed her skills in evaluating drug safety and performing clinical assessments. Additionally, her tenure as a Global Safety Surveillance Operations Associate at Schwarz Biosciences provided her with a robust foundation in global safety surveillance, preparing her for the complex challenges associated with safety and regulatory compliance in the pharmaceutical space.

    Education and Achievements

    Bme Sandra McPhail's academic credentials lay the groundwork for her illustrious career in biomedical engineering and safety sciences. She obtained her Master of Science in Biomedical Engineering with a specialization in Biomaterials Science from the renowned University of North Carolina at Chapel Hill School of Medicine. This advanced education equipped her with a deep understanding of the materials science involved in biomedical applications, emerging technologies, and regulatory frameworks governing the field.

    Prior to her master’s degree, Bme earned her Bachelor of Science in Applied Sciences, also with a focus on Biomaterials Science, from the same prestigious institution. Her education in this field not only highlights her commitment to academic excellence but also reflects her passion for scientific inquiry and innovative solutions in healthcare.

    Notable Achievements

    Throughout her career, Bme Sandra McPhail has achieved significant milestones that underscore her expertise in clinical safety, regulatory compliance, and risk management. Her role as a Director and Global Process Owner at GlaxoSmithKline showcases her leadership capabilities, where she has been responsible for overseeing the periodic reporting of drug safety information, ensuring that all safety evaluations are both thorough and transparent.

    In addition to her managerial roles, Bme has actively engaged in safety evaluation and risk management practices that prioritize patient safety above all. Her collaborative approach has facilitated enhanced communication between regulatory bodies and pharmaceutical companies, ultimately contributing to the development of safer therapeutic products for patients worldwide. Through her roles, she has remained committed to upholding the highest standards of safety and regulatory compliance, which is essential in the fast-evolving landscape of biomedicine and pharmaceuticals.

    Related Questions

    How did Bme Sandra McPhail's education in Biomedical Engineering influence her career in drug safety?
    What specific projects has Bme Sandra McPhail led at GlaxoSmithKline Pharma GmbH in her role as Director and Global Process Owner?
    Can Bme Sandra McPhail share insights on the challenges faced in safety evaluation and risk management within the pharmaceutical industry?
    How has Bme Sandra McPhail leveraged her background in biomaterials science throughout her career?
    In what ways does Bme Sandra McPhail contribute to regulatory compliance in her current role at GlaxoSmithKline?
    Bme Sandra McPhail
    Add to my network

    Location

    Durham, North Carolina, United States